Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients.
about
Challenges and opportunities for the implementation of virological testing in resource-limited settingsDescription of HIV-1 group M molecular epidemiology and drug resistance prevalence in Equatorial Guinea from migrants in SpainPopulation-based monitoring of emerging HIV-1 drug resistance on antiretroviral therapy and associated factors in a sentinel site in Cameroon: low levels of resistance but poor programmatic performanceProfile of the HIV epidemic in Cape Verde: molecular epidemiology and drug resistance mutations among HIV-1 and HIV-2 infected patients from distinct islands of the archipelagoMinority drug-resistant HIV-1 variants in treatment naïve East-African and Caucasian patients detected by allele-specific real-time PCRPersistence of transmitted HIV-1 drug resistance mutations associated with fitness costs and viral genetic backgroundsMonitoring HIV Drug Resistance Early Warning Indicators in Cameroon: A Study Following the Revised World Health Organization RecommendationsDeclining trends in early warning indicators for HIV drug resistance in Cameroon from 2008-2010: lessons and challenges for low-resource settings.Analysis of primary resistance mutations to HIV-1 entry inhibitors in therapy naive subtype C HIV-1 infected mother-infant pairs from Zambia.Optimal starting point for antiretroviral HIV treatment in a town in Cameroon: a randomised controlled studyRates of emergence of HIV drug resistance in resource-limited settings: a systematic review.Use of amplification refractory mutation system PCR assay as a simple and effective tool to detect HIV-1 drug resistance mutations.Modeling dynamic interactions between pre-exposure prophylaxis interventions & treatment programs: predicting HIV transmission & resistancePredictors of poor retention on antiretroviral therapy as a major HIV drug resistance early warning indicator in Cameroon: results from a nationwide systematic random sampling.Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naïve persons in rural western Kenya.Implementation and Operational Research: Risk Factors of Loss to Follow-up Among HIV-Positive Pediatric Patients in Dar es Salaam, Tanzania.Low prevalence of transmitted HIV type 1 drug resistance among antiretroviral-naive adults in a rural HIV clinic in Kenya.Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months' antiretroviral therapy experience in CameroonPrevalence of Transmitted Drug Resistance Mutations in HIV-1-Infected Drug-Naive Patients from Urban and Suburban Regions of Kenya.Genital Shedding of Resistant Human Immunodeficiency Virus-1 Among Women Diagnosed With Treatment Failure by Clinical and Immunologic MonitoringShort communication: HIV type 1 transmitted drug resistance and evidence of transmission clusters among recently infected antiretroviral-naive individuals from Ugandan fishing communities of Lake VictoriaIncreasing HIV-1 pretreatment drug resistance among antiretroviral-naïve adults initiating treatment between 2006 and 2014 in Nairobi, Kenya.HIV virological failure and drug resistance in a cohort of Tanzanian HIV-infected adults.Pretreatment HIV-1 drug resistance is strongly associated with virologic failure in HIV-infected patients receiving partly active antiretroviral regimens.Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis.Increasing rate of TAMs and etravirine resistance in HIV-1-infected adults between 12 and 24 months of treatment: the VOLTART cohort study in Côte d'Ivoire, West Africa.TB and HIV in the Central African region: current knowledge and knowledge gaps.Improved long-term antiretroviral treatment outcomes amongst patients receiving community-based adherence support in South Africa.Virological response, HIV-1 drug resistance mutations and genetic diversity among patients on first-line antiretroviral therapy in N'Djamena, Chad: findings from a cross-sectional study.Increasing Prevalence of HIV Pretreatment Drug Resistance in Women But Not Men in Rural Uganda During 2005-2013
P2860
Q27026923-48C2B417-4222-4F21-A97B-799EF235E3A3Q28533216-C414866E-2F48-4903-8BB0-E20F1CC3D0F1Q28535652-F5E38E93-1480-4068-8961-DCF6464DAE88Q28538242-B5768BBB-6EDA-439D-A1E0-F06878DA3468Q28543986-916CD440-9DD7-49F0-943D-5B56824426A4Q28544845-B6EB23CC-596C-4EF6-9B28-73701DE508DCQ28548432-058E9738-BAE3-4681-A4B8-C63AEAE4B98BQ31114921-FE95112C-BA5A-4E83-B848-063443AE8710Q33597247-98A82CCE-0B2F-4131-891D-77BBCFAF61D4Q34067516-A528DEC5-C030-4A32-B348-519481963052Q34969496-3673DD91-4BB7-4C96-8670-A4A98E3A3C93Q35455456-BBC753A2-C61B-4A24-B879-DD4E97E8AA09Q35619584-97AF444C-0670-4727-95DD-AA398DA35A7EQ36193256-B4714050-3BB7-416B-A1A5-90785AA866C6Q36274049-16984762-5200-4A76-8CBF-6B4D4DD74E2DQ36294353-1316B097-9F16-4F6C-A0BF-6978DA92103DQ36509589-7DD71C9C-54B0-4E4B-97D4-2E8575446424Q36581795-FC8BA8ED-A731-4CC2-9A97-86972CD8273FQ36656752-2FB8933C-CF81-40DB-B0FE-84F7FC22646BQ36667251-881F926D-8DC6-4319-8B11-87542FB2DB50Q36795920-93CC3FE4-DB75-43CB-AAA3-C90B16BDCED7Q36957786-32C2B5FF-83AC-4AFC-99B3-67678E260CCFQ36977381-CFBD93B8-6414-496D-80B4-8FB53C284C61Q37173887-22B2EF84-5E45-4F48-940C-4B582CB9366BQ37216235-88984DE1-8773-4EF1-AF5C-EC8D25A0CF40Q37326870-B8DBFA0C-4903-4C98-8562-9412E6DD270AQ38169113-DB4F03DA-81B6-4DD8-A382-77650EC1FF43Q39717178-09366D0E-A193-4428-BBAA-CD9AC500D85DQ46331291-379CBF83-AD0B-4184-8138-6F680753BC21Q56911534-4615B302-C332-4A3F-8D38-AE3704CB5810
P2860
Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Scale-up of antiretroviral tre ...... ations in drug-naive patients.
@en
Scale-up of antiretroviral tre ...... ations in drug-naive patients.
@nl
type
label
Scale-up of antiretroviral tre ...... ations in drug-naive patients.
@en
Scale-up of antiretroviral tre ...... ations in drug-naive patients.
@nl
prefLabel
Scale-up of antiretroviral tre ...... ations in drug-naive patients.
@en
Scale-up of antiretroviral tre ...... ations in drug-naive patients.
@nl
P2093
P50
P921
P1433
P1476
Scale-up of antiretroviral tre ...... ations in drug-naive patients.
@en
P2093
Arrah Atem-Tambe
Avelin F Aghokeng
Celine Montavon
Christelle Butel
Christian Laurent
Eitel Mpoudi-Ngole
Eugenie Ebong
P304
P356
10.1097/QAD.0B013E32834BBBE9
P407
P577
2011-11-01T00:00:00Z